The Impact of the COVID-19 Response on the Supply Chain, Availability and Cost of Generic Antiretroviral Medicines for HIV in Low- and Middle-income Countries

The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptions.